{"name":"MethylGene Inc.","slug":"methylgene-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"MGCD290","genericName":"MGCD290","slug":"mgcd290","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"MGCD290","genericName":"MGCD290","slug":"mgcd290","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxNWWcyMmFTMGd4bExwM0NUeWdBYWJWX3l3SDg1Y0xTNHdnRURWQUcxMExBdmZsd0JoVWdzMzItVERLTFdNRzVSTU94TWxVbVVhcVJDQVVXS1RaU3huX3liOWhjVHE3bWhNaTRwQkNQNm85VU9DaXU3ajRPa1hPVkhEdkctanVZb0JfaGFZQjRUdzI5RGo4NWtUcGVMdTBSblJVakowbnRVNHlBdTNuWFl0TW12bllUVzRFQnc?oc=5","date":"2021-03-01","type":"pipeline","source":"The Globe and Mail","summary":"First TSX-only biotech IPO in 18 years set for next week as Eupraxia closes books on $41-million offering - The Globe and Mail","headline":"First TSX-only biotech IPO in 18 years set for next week as Eupraxia closes books on $41-million offering","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":0,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}